WEE1 inhibitors may also be synergistic with nucleoside analogue chemotherapy drugs, such as gemcitabine, by reducing the ATR and CHK1 activation induced by gemcitabine exposure of pancreatic cancer cells [89]. The gene discussed is ATR; the disease is pancreatic neoplasm.